by Crestone, Inc. | May 29, 2020 | Press Releases
May 29, 2020 – Announcement: Crestone, Inc. receives $250,000 Grant from State of Colorado Advanced Industries Accelerator program.
by Crestone, Inc. | Apr 27, 2020 | Press Releases
Apr 27, 2020 – Announcement: Crestone, Inc. Secures NIH Funding for Preclinical Development of Novel Antibiotic CRS3123 to Treat H. pylori Infections. Learn More:...
by Crestone, Inc. | Feb 13, 2020 | Press Releases
CFF Funding Secured Crestone, Inc. (Boulder) Secures CFF Funding for Preclinical Development of Novel Antibiotic to Treat NTM Infections. Learn More:...
by Crestone, Inc. | Sep 12, 2019 | Press Releases
Sep 12, 2019 – Announcement: Crestone, Inc. Secures NIH Funding for Phase 2 Clinical Trial of Novel Antibiotic Candidate, CRS3123 to Treat C. difficile infection. Learn More:...
by Crestone, Inc. | Apr 14, 2019 | Events
Presentation Overview Crestone, Inc. presents at the 29th ECCMID in Amsterdam, Netherlands. Oral Session: Mode of Action, Spectrum of Activity, and Preclinical in vivo Efficacy of CRS0540, a PolC DNA Polymerase Inhibitor of Resistant Gram-positive...
